CME-Certified Medical Minute: ESMO

Share

Program Content

Activities

  • Review of BTKi for CLL and MCL
    A Year in Review: Expert Perspectives on Current and Emerging Data With BTK Inhibitors for CLL and MCL
    Conference Coverage
    Text Module
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 05, 2023

    Expires: December 04, 2024

Faculty

cover img faculity

Ana Marin-Niebla, MD, PhD

Hematology Consultant, Lymphoma Unit
Vall d'Hebron Institute of Oncology, Hematology Department
Hospital Universitario Vall d'Hebron
Barcelona, Spain

cover img faculity

Stephan Stilgenbauer, MD

Medical Director Comprehensive Cancer Center Ulm
Head, Early Clinical Trials Unit
Head, Division of CLL Dept. of Internal Medicine III
University Medical Center
Ulm University
Ulm, Germany

Provided by

ProCE Banner

Supporters

Supported by an educational grant from Lilly.

Lilly